NCT00504816View on ClinicalTrials.gov

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2008

Conditions
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
Interventions
DRUG

GSK189075

Given with Brevicon to determine any effects of GSK189075 on Brevicon PK.

DRUG

Brevicon

Given with GSK189075 to determine if GSK189075 exerts an effect on GSK189075 PK.

Trial Locations (1)

33025

GSK Investigational Site, Miramar

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY